Detalhe da pesquisa
1.
Coregulation of pathways in lung cancer patients with EGFR mutation: therapeutic opportunities.
Br J Cancer
; 125(12): 1602-1611, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34373568
2.
Targeting PKCι-PAK1 signaling pathways in EGFR and KRAS mutant adenocarcinoma and lung squamous cell carcinoma.
Cell Commun Signal
; 17(1): 137, 2019 10 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-31660987
3.
Nuclear IGF-1R predicts chemotherapy and targeted therapy resistance in metastatic colorectal cancer.
Br J Cancer
; 117(12): 1777-1786, 2017 Dec 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29123263
4.
LoVo colon cancer cells resistant to oxaliplatin overexpress c-MET and VEGFR-1 and respond to VEGF with dephosphorylation of c-MET.
Mol Carcinog
; 55(5): 411-9, 2016 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25647613
5.
KRAS G12C-mutant driven non-small cell lung cancer (NSCLC).
Crit Rev Oncol Hematol
; 195: 104228, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38072173
6.
Vaccine antibodies against a synthetic epidermal growth factor variant enhance the antitumor effects of inhibitors targeting the MAPK/ERK and PI3K/Akt pathways.
Transl Oncol
; 40: 101878, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38183801
7.
HMGB1 Expression Levels Correlate with Response to Immunotherapy in Non-Small Cell Lung Cancer.
Lung Cancer (Auckl)
; 15: 55-67, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38741920
8.
Nuclear factor-kappa B and interleukin-6 related docetaxel resistance in castration-resistant prostate cancer.
Prostate
; 73(5): 512-21, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23038213
9.
The role of biomarkers in stage III non-small cell lung cancer.
Expert Rev Respir Med
; 17(6): 469-480, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37317885
10.
Biological insights in non-small cell lung cancer.
Cancer Biol Med
; 20(7)2023 06 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-37381723
11.
Anti-EGF nanobodies enhance the antitumoral effect of osimertinib and overcome resistance in non-small cell lung cancer (NSCLC) cellular models.
Med Oncol
; 39(12): 195, 2022 Sep 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36071367
12.
Anti-epidermal growth factor vaccine antibodies increase the antitumor activity of kinase inhibitors in ALK and RET rearranged lung cancer cells.
Transl Oncol
; 14(1): 100887, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-33129112
13.
A narrative review of the migration and invasion features of non-small cell lung cancer cells upon xenobiotic exposure: insights from in vitro studies.
Transl Lung Cancer Res
; 10(6): 2698-2714, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-34295671
14.
Src-Homology 2 Domain-Containing Phosphatase 2 in Resected EGFR Mutation-Positive Lung Adenocarcinoma.
JTO Clin Res Rep
; 1(4): 100084, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34589963
15.
SRC and PIM1 as potential co-targets to overcome resistance in MET deregulated non-small cell lung cancer.
Transl Lung Cancer Res
; 9(5): 1810-1821, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-33209603
16.
Serum IGF-I, IGFBP-3, and matrix metalloproteinase-7 levels and acquired chemo-resistance in advanced colorectal cancer.
Endocr Relat Cancer
; 16(1): 311-7, 2009 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-19109398
17.
Serum matrilysin levels predict outcome in curatively resected colorectal cancer patients.
Ann Surg Oncol
; 16(5): 1412-20, 2009 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-19259740
18.
Cancer Stem Cell Biomarkers in EGFR-Mutation-Positive Non-Small-Cell Lung Cancer.
Clin Lung Cancer
; 20(3): 167-177, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30885551
19.
Osimertinib and pterostilbene in EGFR-mutation-positive non-small cell lung cancer (NSCLC).
Int J Biol Sci
; 15(12): 2607-2614, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31754333
20.
Integrin-linked kinase (ILK) and src homology 2 domain-containing phosphatase 2 (SHP2): Novel targets in EGFR-mutation positive non-small cell lung cancer (NSCLC).
EBioMedicine
; 39: 207-214, 2019 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-30473379